| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |